0 items USD 0.00Search
Your search for "gir global insulin lispro market 2019 manufacturers regions type application forecast 2024" gave back 48391 results.
The global Insulin Lispro market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Insulin Lispro market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin Lispro is forecast to...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Biosimilar Insulin market size was valued at USD 2632.1 million in 2023 and is forecast to a readjusted size of USD 6421.8 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Summary Insulin Lispro market research report provides the newest industry data and industry future trends, allowing you to identify the products and...
Catalog:
ICRW
March 2020
Price: USD 2,960.00
Insulin lispro Sanofi is a 'biosimilar medicine'. This means that it is highly similar to a biological medicine (also known as the '...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Lantus (insulin glargine) is an effective, long-acting insulin that provides all-day blood sugar control, but it can cause low blood sugar levels, so...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Summary Insulin Lispro market research report provides the newest industry data and industry future trends, allowing you to identify the products and...
Catalog:
ICRW
March 2021
Price: USD 2,960.00
The global Fast-acting Human Insulin market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
November 2023
Price: USD 3,480.00
The global Biosimilar Insulin market size was valued at US$ 2502.4 million in 2023. With growing demand in downstream market, the Biosimilar Insulin...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Biosimilar insulin is a biological copy of an original insulin and there is increasing interest in developing and using them. Biosimilar insulins (...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The global Fast-acting Human Insulin market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
November 2023
Price: USD 4,480.00
The global Fast-acting Human Insulin market size was valued at US$ million in 2022. With growing demand in downstream market, the Fast-acting Human...
Catalog:
LPI
November 2023
Price: USD 3,660.00
Biosimilar insulin is a biological copy of an original insulin and there is increasing interest in developing and using them. Biosimilar insulins (...
Catalog:
LPI
January 2023
Price: USD 3,660.00
